Kun Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kun Yang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bichen Ren
Department of Vascular Surgery, Institute of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. (L.C., L.Y., B.R., P.W., Z.D.)
1 shared publication - Bo Li
Key Laboratory of Anesthesiology (Shanghai Jiao Tong University) Ministry of Education Pudong Shanghai China
1 shared publication - Hsiao-Hwa Chen
Department of Engineering Science, National Cheng Kung University, Tainan, Taiwan
1 shared publication - Jiahui Cheng
Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, China (J.C., Y.Z., B.L.).
1 shared publication Jianxin Chen
Department of Cardiac Surgery (R.G., Jianxin Chen, J.J., K.Y.), The Second Affiliated Hospital, Zhejiang University, Hangzhou, China
1 shared publicationJiaran Shi
Department of Cardiology, Lihuili Hospital Facilitated to Ningbo University, China (J.S.).
1 shared publication
Latest Publications
- 1 June 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (6) , 928-944
ALKBH5 Regulates Macrophage Senescence and Accelerates Atherosclerosis by Promoting CCL5 m 6 A Modification
BACKGROUND: Senescent foamy macrophages are key drivers of atherosclerosis and plaque instability. N 6 -methyladenosine (m 6 A) modification of RNA plays an important role in the development of various diseases including aging. Here, we aim to investigate the role of m 6 A modification of RNA in the formation of senescent foamy macrophages in atherosclerosis. METHODS: To assess m 6 A methylation, macrophages were isolated from the atherosclerotic plaques of patients with atherosclerosis, and Apoe −/− mice were fed a high-fat diet using flow cytometry. An ALKBH5 (alkB homolog 5) f/f , Lyz2 (lysozyme 2) Cre , Apoe −/− mouse model was generated to determine the infiltration of senescent foamy macrophages into plaques and atherosclerosis progression. Methylated RNA immunoprecipitation, RNA immunoprecipitation sequencing, and dual-luciferase assays were performed to explore the mechanisms underlying the ALKBH5-mediated formation of senescent foamy macrophages. RESULTS: Decreased m 6 A methylation and increased ALKBH5 expression were observed in arterial plaques and infiltrating macrophages from patients and mice with atherosclerosis. Compared with control mice, ALKBH5 f/f , Lyz2 Cre , Apoe −/− mice exhibited fewer atherosclerosis plaques with greater stability, which was attributed to the suppression of senescent foamy macrophage formation and senescence-associated secretory phenotype. In addition, ALKBH5 deletion reduced the mRNA expression level of CCL5 (CC chemokine ligand 5) by increasing m 6 A methylation in macrophages, which disrupts the stability of CCL5 mRNA. Mechanistically, ALKBH5 promoted senescent foamy macrophage formation through the CCL5/CCR5 (CC chemokine receptor 5)/autophagy signaling pathway. CCL5 also recruited CD8 + IFN (interferon)γ + T cells via the CCL5-CCR5 axis. The ALKBH5 inhibitor IOX1 (inhibitor of 2OG oxygenases) and the CCR5 antagonist maraviroc were identified as potential clinical interventions for inhibiting senescent foamy macrophage formation and atherosclerosis progression. CONCLUSIONS: Myeloid ALKBH5 deletion attenuates atherosclerosis progression by suppressing the formation of senescent foamy macrophages and the recruitment of CD8 + IFNγ + T cells. These findings identify ALKBH5, CCL5, and CCR5 as novel therapeutic targets for atherosclerosis.
- 1 June 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (6) , 928-944
ALKBH5 Regulates Macrophage Senescence and Accelerates Atherosclerosis by Promoting CCL5 m 6 A Modification
BACKGROUND: Senescent foamy macrophages are key drivers of atherosclerosis and plaque instability. N 6 -methyladenosine (m 6 A) modification of RNA plays an important role in the development of various diseases including aging. Here, we aim to investigate the role of m 6 A modification of RNA in the formation of senescent foamy macrophages in atherosclerosis. METHODS: To assess m 6 A methylation, macrophages were isolated from the atherosclerotic plaques of patients with atherosclerosis, and Apoe −/− mice were fed a high-fat diet using flow cytometry. An ALKBH5 (alkB homolog 5) f/f , Lyz2 (lysozyme 2) Cre , Apoe −/− mouse model was generated to determine the infiltration of senescent foamy macrophages into plaques and atherosclerosis progression. Methylated RNA immunoprecipitation, RNA immunoprecipitation sequencing, and dual-luciferase assays were performed to explore the mechanisms underlying the ALKBH5-mediated formation of senescent foamy macrophages. RESULTS: Decreased m 6 A methylation and increased ALKBH5 expression were observed in arterial plaques and infiltrating macrophages from patients and mice with atherosclerosis. Compared with control mice, ALKBH5 f/f , Lyz2 Cre , Apoe −/− mice exhibited fewer atherosclerosis plaques with greater stability, which was attributed to the suppression of senescent foamy macrophage formation and senescence-associated secretory phenotype. In addition, ALKBH5 deletion reduced the mRNA expression level of CCL5 (CC chemokine ligand 5) by increasing m 6 A methylation in macrophages, which disrupts the stability of CCL5 mRNA. Mechanistically, ALKBH5 promoted senescent foamy macrophage formation through the CCL5/CCR5 (CC chemokine receptor 5)/autophagy signaling pathway. CCL5 also recruited CD8 + IFN (interferon)γ + T cells via the CCL5-CCR5 axis. The ALKBH5 inhibitor IOX1 (inhibitor of 2OG oxygenases) and the CCR5 antagonist maraviroc were identified as potential clinical interventions for inhibiting senescent foamy macrophage formation and atherosclerosis progression. CONCLUSIONS: Myeloid ALKBH5 deletion attenuates atherosclerosis progression by suppressing the formation of senescent foamy macrophages and the recruitment of CD8 + IFNγ + T cells. These findings identify ALKBH5, CCL5, and CCR5 as novel therapeutic targets for atherosclerosis.
- 9 October 2009
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Wireless Communications
- Vol. 16 (4) , 64-71
Topology control for service-oriented wireless mesh networks
Topology control is one of the most critical design issues in multihop wireless networks. Topology control has been investigated extensively in the literature. Nevertheless, it is noted that most existing studies do not consider the requirements on upper layer applications or services. In this article we address the topology control issues on service-oriented wireless mesh networks. In particular, we provide a comprehensive survey of existing works on topology control from a service- oriented perspective. We then propose a general framework for topology control in service- oriented WMNs. To demonstrate the effectiveness of the framework, we conduct a case study in which the main objective is to maximize the overall throughput in a network with random unicast traffic. The performance of this topology control scheme is evaluated by numerical results. In addition, it is illustrated that the generated topology can support advanced technologies, including network coding and physical-layer network coding, which can significantly improve the throughput capacity of a network.
- 9 October 2009
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Wireless Communications
- Vol. 16 (4) , 64-71
Topology control for service-oriented wireless mesh networks
Topology control is one of the most critical design issues in multihop wireless networks. Topology control has been investigated extensively in the literature. Nevertheless, it is noted that most existing studies do not consider the requirements on upper layer applications or services. In this article we address the topology control issues on service-oriented wireless mesh networks. In particular, we provide a comprehensive survey of existing works on topology control from a service- oriented perspective. We then propose a general framework for topology control in service- oriented WMNs. To demonstrate the effectiveness of the framework, we conduct a case study in which the main objective is to maximize the overall throughput in a network with random unicast traffic. The performance of this topology control scheme is evaluated by numerical results. In addition, it is illustrated that the generated topology can support advanced technologies, including network coding and physical-layer network coding, which can significantly improve the throughput capacity of a network.